Surya K. De

4.0k total citations
121 papers, 3.2k citations indexed

About

Surya K. De is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Surya K. De has authored 121 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Organic Chemistry, 50 papers in Molecular Biology and 11 papers in Inorganic Chemistry. Recurrent topics in Surya K. De's work include Chemical Synthesis and Reactions (39 papers), Multicomponent Synthesis of Heterocycles (19 papers) and Chemical Synthesis and Analysis (15 papers). Surya K. De is often cited by papers focused on Chemical Synthesis and Reactions (39 papers), Multicomponent Synthesis of Heterocycles (19 papers) and Chemical Synthesis and Analysis (15 papers). Surya K. De collaborates with scholars based in United States, India and United Kingdom. Surya K. De's co-authors include Richard A. Gibbs, Maurizio Pellecchia, Elisa Barile, John L. Stebbins, Bainan Wu, Ze’ev A. Ronai, Megan Riel‐Mehan, Li‐Hsing Chen, Thomas Machleidt and Aras Emdadi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Surya K. De

111 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Surya K. De United States 33 2.0k 1.3k 312 236 209 121 3.2k
Joachim Rudolph United States 27 1.1k 0.5× 1.6k 1.2× 515 1.7× 207 0.9× 390 1.9× 61 3.0k
Tao Lu China 33 2.1k 1.0× 1.3k 1.0× 330 1.1× 239 1.0× 112 0.5× 176 3.3k
William R. Ewing United States 28 2.0k 1.0× 955 0.7× 165 0.5× 412 1.7× 153 0.7× 63 3.1k
Zhaopeng Liu China 25 869 0.4× 849 0.6× 241 0.8× 154 0.7× 211 1.0× 127 2.1k
Runtao Li China 29 2.1k 1.0× 1.0k 0.8× 251 0.8× 271 1.1× 164 0.8× 166 2.9k
Daniel L. Flynn United States 30 1.3k 0.6× 1.2k 0.9× 245 0.8× 138 0.6× 62 0.3× 100 2.4k
Aya Tanatani Japan 30 1.8k 0.9× 1.2k 0.9× 122 0.4× 249 1.1× 400 1.9× 101 2.8k
Chunhao Yang China 29 1.4k 0.7× 745 0.6× 290 0.9× 143 0.6× 57 0.3× 136 2.4k
Xiaohua Huang United States 24 4.4k 2.2× 1.2k 0.9× 118 0.4× 699 3.0× 229 1.1× 61 5.3k
Joseph M. Salvino United States 34 1.2k 0.6× 2.3k 1.7× 691 2.2× 79 0.3× 108 0.5× 106 3.7k

Countries citing papers authored by Surya K. De

Since Specialization
Citations

This map shows the geographic impact of Surya K. De's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surya K. De with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surya K. De more than expected).

Fields of papers citing papers by Surya K. De

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surya K. De. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surya K. De. The network helps show where Surya K. De may publish in the future.

Co-authorship network of co-authors of Surya K. De

This figure shows the co-authorship network connecting the top 25 collaborators of Surya K. De. A scholar is included among the top collaborators of Surya K. De based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surya K. De. Surya K. De is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
De, Surya K.. (2024). Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome. Frontiers in Pharmacology. 15. 1337436–1337436. 2 indexed citations
2.
De, Surya K.. (2024). Drug Design and Discovery.
3.
De, Surya K.. (2023). Discovery of Novel Cysteine Protease Inhibitors for the Treatment ofCoronavirus (COVID-19). Current Medicinal Chemistry. 31(9). 1165–1169. 1 indexed citations
4.
De, Surya K.. (2023). Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors forTreating Cancer and other Diseases. Current Medicinal Chemistry. 31(34). 5657–5659. 1 indexed citations
5.
De, Surya K.. (2023). Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer. Anti-Cancer Agents in Medicinal Chemistry. 23(14). 1697–1700.
6.
Chan, Xin Hui S, Emily Martyn, Rob Shulman, et al.. (2022). Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality. Journal of Hospital Infection. 124. 37–46. 9 indexed citations
7.
Wu, Bainan, Surya K. De, Anna Kulinich, et al.. (2017). Potent and Selective EphA4 Agonists for the Treatment of ALS. Cell chemical biology. 24(3). 293–305. 38 indexed citations
8.
Barile, Elisa, Guya Diletta Marconi, Surya K. De, et al.. (2016). hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents. ACS Chemical Biology. 12(2). 444–455. 32 indexed citations
9.
Nakanishi, Yuki, Miguel Reina‐Campos, Naoko Nakanishi, et al.. (2016). Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι. Cell Reports. 16(12). 3297–3310. 49 indexed citations
10.
Scortegagna, Marzia, Eric Lau, Tongwu Zhang, et al.. (2015). PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets. Cancer Research. 75(7). 1399–1412. 44 indexed citations
11.
Feng, Yongmei, Anthony B. Pinkerton, Laura Hulea, et al.. (2015). SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex. Cancer Research. 75(24). 5211–5218. 26 indexed citations
12.
Pal, Ipsita, Siddik Sarkar, Shashi Rajput, et al.. (2014). BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt. British Journal of Cancer. 111(1). 101–111. 10 indexed citations
13.
Scortegagna, Marzia, Chelsea M. Ruller, Yongmei Feng, et al.. (2013). Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of BrafV600E::Pten–/– melanoma. Oncogene. 33(34). 4330–4339. 56 indexed citations
14.
Stebbins, John L., Eugenio Santelli, Yongmei Feng, et al.. (2013). Structure-Based Design of Covalent Siah Inhibitors. Chemistry & Biology. 20(8). 973–982. 46 indexed citations
15.
Ingeniis, Jessica De, Boris I. Ratnikov, Adam Richardson, et al.. (2012). Functional Specialization in Proline Biosynthesis of Melanoma. PLoS ONE. 7(9). e45190–e45190. 129 indexed citations
16.
De, Surya K., Elisa Barile, John L. Stebbins, et al.. (2011). Design, synthesis, and structure–activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase. Bioorganic & Medicinal Chemistry. 19(8). 2582–2588. 13 indexed citations
17.
Stebbins, John L., Surya K. De, Thomas Machleidt, et al.. (2008). Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proceedings of the National Academy of Sciences. 105(43). 16809–16813. 157 indexed citations
18.
De, Surya K.. (2005). Cobalt(II) chloride catalyzed one-pot synthesis of α-aminonitriles. Beilstein Journal of Organic Chemistry. 1(1). 8–8. 6 indexed citations
19.
De, Abhijit, Surya K. De, Asok K. Mallik, & Tapan Ganguly. (2001). Studies on unimolecular and bimolecular photoprocesses of a newly synthesized selenium compound, 7-chloro-2-phenyl-9H-[1]-benzopyrano[3,2-b]-selenophene-9-one (SeP). Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 57(7). 1427–1441. 3 indexed citations
20.
De, Surya K., et al.. (1997). A convenient synthesis of 1,2-diphenyl-9 H -[1]benzopyrano [3,2 -b ] pyrrol-9-ones utilizing hypervalent iodine reagent. INDIAN JOURNAL OF CHEMISTRY- SECTION A. 36(6). 536–537.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim Rudolph Breakdown of academic impact, for papers by Tao Lu Breakdown of academic impact, for papers by William R. Ewing Breakdown of academic impact, for papers by Zhaopeng Liu Breakdown of academic impact, for papers by Runtao Li Breakdown of academic impact, for papers by Daniel L. Flynn Breakdown of academic impact, for papers by Aya Tanatani Breakdown of academic impact, for papers by Chunhao Yang Breakdown of academic impact, for papers by Xiaohua Huang Breakdown of academic impact, for papers by Joseph M. Salvino
Rankless by CCL
2026